Company
MiNK Therapeutics, Inc.
INKT · CIK 0001840229
Acquisition (code A) of 1,633 shares at $10.95 per share.
Reporting Person Corvese Brian · Transaction Code A
Traded Sep 1, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001193125-26-379513 · filed 2026-09-02 · View filing →
Acquisition (code A) of 1,622 shares at $10.95 per share.
Reporting Person Ryan Barbara · Transaction Code A
Traded Sep 1, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001193125-26-379518 · filed 2026-09-02 · View filing →
Acquisition (code A) of 1,485 shares at $10.95 per share.
Reporting Person Behner Peter · Transaction Code A
Traded Sep 1, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001193125-26-379522 · filed 2026-09-02 · View filing →
Acquisition (code A) of 1,233 shares at $10.95 per share.
Reporting Person Holcomb John Bradley · Transaction Code A
Traded Sep 1, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001193125-26-379524 · filed 2026-09-02 · View filing →
Acquisition (code A) of 1,279 shares at $10.95 per share.
Reporting Person WIINBERG ULF · Transaction Code A
Traded Sep 1, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001193125-26-379575 · filed 2026-09-02 · View filing →